Want wealth compounding? Here are my 3 favourite dividend shares inside the ASX 300

I think these companies will be dishing out dividends for many years to come.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Finding dividend-paying companies that will keep paying for many years to come can net sensational returns
  • I would invest in ASX shares that have strong brands and a history of growing dividends
  • Even a modest amount of money can become a large sum thanks to compounding

When it comes to building wealth through investing, there are few strategies more effective than compounding. By reinvesting your dividends, you can harness the power of compounding to grow your portfolio over time. But not all ASX dividend shares are created equal.

Identifying companies that can stand the test of time should be a priority if building life-changing wealth over decades is the plan. There's little point in finding an investment with a high yield now if it goes bust five years later — undoing all of the prior compoundings.

That's why I would focus on companies within the ASX 300 with a competitive edge and a long history of growing dividends.

Let's take a look at three companies that I believe best fit the bill.

Retailers with strong and growing brands

The accumulated value of a brand built over decades can be a wide and defendable moat. Humans tend to unconsciously gravitate toward companies they know and trust, even if it means sometimes paying more than at a lesser-known competitor.

Two dividend shares I reckon are prime examples of this familiarity bias in action are Super Retail Group Ltd (ASX: SUL) and Premier Investments Limited (ASX: PMV). Kicking off in 1972 and 1987, respectively, both companies have a long track record of providing quality products at affordable prices.

While growing their customer bases over the years through additional stores and brands, these two retailers have amplified their earnings. Similarly, dividends have gradually trended higher during their listed lives, as shown below.

TradingView Chart

Aside from Super Retail Group experiencing a blip during the pandemic, dividends have steadily increased over time.

In my opinion, both Premier Investments and Super Retail Group have a good chance of compounding into the future. This is because both of these ASX dividend shares are still rapidly growing their brands.

For example, Super Retail achieved 55% sales growth of its Macpac brand in the first half of FY2023. Likewise, Premier Investments revealed record half-year results today. The retail conglomerate's global sales of its Smiggle brand increased 30.3%, and Peter Alexander's sales reached a record $261.7 million — up 15.1% year on year.

Possible future dividend aristocrat inside the ASX 300

The crème de la crème of the compounding is a dividend aristocrat — companies that have upped their dividends for 25 consecutive years or more.

Even an initial investment of around $5,000 can grow to considerable wealth over 15 years, assuming the company increases its dividends by roughly 10% per annum and the share price rises 5% each year.

Assuming dividends are reinvested, such a hypothetical investment could grow to more than $20,000, as illustrated below.

Note: For illustrative purposes only.

Unfortunately, there aren't any ASX 300 shares — or ASX companies, period — that meet the stringent criteria of an aristocrat. However, if we loosen the conditions to include ASX shares that have not reduced their dividends over the same time, Sonic Healthcare Limited (ASX: SHL) gets pretty close.

The laboratory and pathology giant has not once cut its dividends over 20 years. An exceptional history if ever I've seen one.

I believe Sonic's positioning in a defensive market bodes well as a multi-decade investment. The company's strong balance sheet and involvement in molecular diagnostics could fuel future years of compounding, in my opinion.

Motley Fool contributor Mitchell Lawler has positions in Sonic Healthcare. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Super Retail Group. The Motley Fool Australia has positions in and has recommended Super Retail Group. The Motley Fool Australia has recommended Premier Investments and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Happy young couple saving money in piggy bank.
Opinions

Want to start investing in ASX shares? Here's what I'd buy

This is where I’d begin to put my money in the stock market.

Read more »

People of different ethnicities in a room taking a big selfie, symbolising diversification.
Opinions

Want diversification? Get it instantly with these ASX 200 shares

Some businesses offer a lot more diversification than others.

Read more »

A happy man and woman on a computer at Christmas, indicating a positive trend for retail shares.
Opinions

2 ASX 200 shares I'd want to receive as a present today

Merry Christmas! Are there any stocks under your tree?

Read more »

Young boy in business suit punches the air as he finishes ahead of another boy in a box car race.
Opinions

Why I think these 2 ASX 300 stocks will beat the market in 2025

I’m very optimistic about a few ASX growth shares.

Read more »

A businessman compares the growth trajectory of property versus shares.
Opinions

What's the outlook for shares vs. property in 2025?

The experts have put out their new year predictions...

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Opinions

My ASX share portfolio is up 30% this year! Here's my plan for 2025

The best investing plans shouldn't need too many updates.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Opinions

These stocks made my share portfolio a market-beater in 2024

Beating the market is the least important takeaway from this year.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Opinions

2 underappreciated ASX 200 shares to buy now

Investors may be undervaluing these ASX 200 shares heading into 2025, according to this expert.

Read more »